Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization.

Tadrous M, Knowles S, Ruddock B, Oh P, Mamdani MM, Juurlink DN, Gomes T.

Int J Technol Assess Health Care. 2019 Dec 3:1-8. doi: 10.1017/S0266462319000746. [Epub ahead of print]

PMID:
31796132
2.

Nursing resource team capacity planning using forecasting and optimization methods: a case study.

Kaw N, Murray J, Lopez AJ, Mamdani MM.

J Nurs Manag. 2019 Nov 16. doi: 10.1111/jonm.12905. [Epub ahead of print]

PMID:
31733153
3.

Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial.

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team.

JAMA Intern Med. 2019 Oct 7. doi: 10.1001/jamainternmed.2019.4472. [Epub ahead of print]

4.

Linking Quality Improvement and Health Information Technology through the QI-HIT Figure 8.

Jamieson T, Mamdani MM, Etchells E.

Appl Clin Inform. 2019 May;10(3):528-533. doi: 10.1055/s-0039-1693456. Epub 2019 Jul 24.

PMID:
31340398
5.

Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort Study.

Tadrous M, Matta R, Greaves S, Herschorn S, Mamdani MM, Juurlink DN, Gomes T.

JAMA Intern Med. 2019 Jul 15. doi: 10.1001/jamainternmed.2019.2011. [Epub ahead of print] No abstract available.

PMID:
31305875
6.

Impact of delisting high-strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada.

Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T; Ontario Drug Policy Research Network.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):726-733. doi: 10.1002/pds.4764. Epub 2019 Mar 14.

7.

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits.

Morrow RL, Dormuth CR, Paterson M, Mamdani MM, Gomes T, Juurlink DN; Canadian Drug Safety Effectiveness Research Network (CDSERN).

BMJ Open. 2019 Mar 13;9(3):e026705. doi: 10.1136/bmjopen-2018-026705.

8.

Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.

Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, Juurlink DN, Gomes T.

Int J Drug Policy. 2019 Apr;66:82-86. doi: 10.1016/j.drugpo.2019.01.025. Epub 2019 Feb 8.

PMID:
30743092
9.

Large care gaps in primary care management of asthma: a longitudinal practice audit.

Price C, Agarwal G, Chan D, Goel S, Kaplan AG, Boulet LP, Mamdani MM, Straus SE, Lebovic G, Gupta S.

BMJ Open. 2019 Jan 29;9(1):e022506. doi: 10.1136/bmjopen-2018-022506.

10.

The Burden of Opioid-Related Mortality in the United States.

Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.

11.

Analysis of Trends in Insulin Utilization and Spending Across Canada From 2010 to 2015.

Xu Y, Gomes T, Mamdani MM, Juurlink DN, Cadarette SM, Tadrous M.

Can J Diabetes. 2019 Apr;43(3):179-185.e1. doi: 10.1016/j.jcjd.2018.08.190. Epub 2018 Aug 16.

PMID:
30545737
12.

Mortality in Puerto Rico after Hurricane Maria.

Verma AA, Murray J, Mamdani MM.

N Engl J Med. 2018 Oct 25;379(17):e30. doi: 10.1056/NEJMc1810872. No abstract available.

PMID:
30358975
13.

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.

14.

Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D, Juurlink DN.

Ann Intern Med. 2018 Nov 20;169(10):732-734. doi: 10.7326/M18-1136. Epub 2018 Aug 21. No abstract available.

PMID:
30140853
15.

Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.

16.

Xylitol for the prevention of acute otitis media episodes in children aged 2-4 years: protocol for a pragmatic randomised controlled trial.

Persaud N, Laupacis A, Azarpazhooh A, Birken C, Hoch JS, Isaranuwatchai W, Maguire JL, Mamdani MM, Thorpe K, Allen C, Mason D, Kowal C, Bazeghi F, Parkin P; TARGet Kids! Collaboration.

BMJ Open. 2018 Aug 5;8(8):e020941. doi: 10.1136/bmjopen-2017-020941.

17.

Second-generation anti-depressants and risk of new-onset seizures in the elderly.

Finkelstein Y, Macdonald EM, Li P, Mamdani MM, Gomes T, Juurlink DN.

Clin Toxicol (Phila). 2018 Dec;56(12):1179-1184. doi: 10.1080/15563650.2018.1483025. Epub 2018 Jul 10.

PMID:
29989445
18.

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.

Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM.

PLoS Med. 2018 Jun 11;15(6):e1002584. doi: 10.1371/journal.pmed.1002584. eCollection 2018 Jun.

19.

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride.

Antoniou T, Macdonald EM, Yao Z, Gomes T, Tadrous M, Ho JM, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMC Musculoskelet Disord. 2018 May 22;19(1):160. doi: 10.1186/s12891-018-2076-9.

20.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

21.

Measuring the Burden of Opioid-related Mortality in Ontario, Canada.

Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN.

J Addict Med. 2018 Sep/Oct;12(5):418-419. doi: 10.1097/ADM.0000000000000412. No abstract available.

22.

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study.

Tadrous M, Brahmania M, Martins D, Knowles S, Janssen HLA, Mamdani MM, Juurlink DN, Gomes T.

J Manag Care Spec Pharm. 2018 May;24(5):464-468. doi: 10.18553/jmcp.2018.24.5.464.

23.

Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program.

Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T.

CMAJ Open. 2018 Mar 14;6(1):E132-E138. doi: 10.9778/cmajo.20170132.

24.

Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T.

Can Urol Assoc J. 2018 Mar;12(3):E142-E145. doi: 10.5489/cuaj.4541. Epub 2017 Dec 22.

25.

Patient characteristics, resource use and outcomes associated with general internal medicine hospital care: the General Medicine Inpatient Initiative (GEMINI) retrospective cohort study.

Verma AA, Guo Y, Kwan JL, Lapointe-Shaw L, Rawal S, Tang T, Weinerman A, Cram P, Dhalla IA, Hwang SW, Laupacis A, Mamdani MM, Shadowitz S, Upshur R, Reid RJ, Razak F.

CMAJ Open. 2017 Dec 11;5(4):E842-E849. doi: 10.9778/cmajo.20170097. Epub 2017 Dec 13.

26.

Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study.

So M, Mamdani MM, Morris AM, Lau TTY, Broady R, Deotare U, Grant J, Kim D, Schimmer AD, Schuh AC, Shajari S, Steinberg M, Bell CM, Husain S.

Clin Microbiol Infect. 2018 Aug;24(8):882-888. doi: 10.1016/j.cmi.2017.11.009. Epub 2017 Nov 11.

27.

Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.

Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):59-65.e2. doi: 10.1016/j.anai.2017.08.016. Epub 2017 Oct 3.

PMID:
28986124
28.

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W.

PLoS Med. 2017 Oct 3;14(10):e1002396. doi: 10.1371/journal.pmed.1002396. eCollection 2017 Oct.

29.

Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada.

Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W.

Drug Alcohol Depend. 2017 Oct 1;179:416-423. doi: 10.1016/j.drugalcdep.2017.07.008. Epub 2017 Aug 5.

PMID:
28867560
30.

Pregabalin and heart failure: A population-based study.

Ho JM, Macdonald EM, Luo J, Gomes T, Antoniou T, Mamdani MM, Juurlink DN.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1087-1092. doi: 10.1002/pds.4239. Epub 2017 Jun 16.

PMID:
28620909
31.

Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study.

Quinn KL, Macdonald EM, Mamdani MM, Diong C, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Oct;40(10):887-893. doi: 10.1007/s40264-017-0552-z.

PMID:
28620871
32.

Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial.

Persaud N, Lee T, Ahmad H, Li W, Taglione MS, Rajakulasingam Y, Umali N, Boozary A, Glazier RH, Gomes T, Hwang SW, Jüni P, Law M, Mamdani MM, Manns B, Martin D, Morgan S, Oh P, Pinto AD, Shah BR, Sullivan FM, Thorpe KE, Tu K, Laupacis A.

BMJ Open. 2017 Jun 12;7(5):e015686. doi: 10.1136/bmjopen-2016-015686.

33.

More Rigorous Study Needed Before Claiming No Harm of Blood Glucose Test Strip Limits for Patients Using Insulin-Reply.

Gomes T, Shah BR, Mamdani MM.

JAMA Intern Med. 2017 Jun 1;177(6):890-891. doi: 10.1001/jamainternmed.2017.1089. No abstract available.

PMID:
28586809
34.

Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.

Quinn KL, Macdonald EM, Gomes T, Mamdani MM, Huang A, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

Drug Saf. 2017 Sep;40(9):835-840. doi: 10.1007/s40264-017-0539-9.

PMID:
28421551
35.

Lipophilic β-Blockers and Suicide in the Elderly.

Zipursky JS, Macdonald EM, Luo J, Gomes T, Mamdani MM, Paterson JM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Clin Psychopharmacol. 2017 Jun;37(3):381-384. doi: 10.1097/JCP.0000000000000695. No abstract available.

PMID:
28338548
36.

Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation.

Antoniou T, Macdonald EM, Yao Z, Hollands S, Gomes T, Tadrous M, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

CMAJ. 2017 Jan 9;189(1):E4-E10. doi: 10.1503/cmaj.160303. Epub 2016 Nov 21.

37.

Overdose Risk in Young Children of Women Prescribed Opioids.

Finkelstein Y, Macdonald EM, Gonzalez A, Sivilotti MLA, Mamdani MM, Juurlink DN; Canadian Drug Safety And Effectiveness Research Network (CDSERN).

Pediatrics. 2017 Mar;139(3). pii: e20162887. doi: 10.1542/peds.2016-2887. Epub 2017 Feb 20.

38.

Practice Doesn't Always Make Perfect: A Qualitative Study Explaining Why a Trial of an Educational Toolkit Did Not Improve Quality of Care.

Parsons JA, Yu CH, Baker NA, Mamdani MM, Bhattacharyya O, Zwarenstein M, Shah BR.

PLoS One. 2016 Dec 28;11(12):e0167878. doi: 10.1371/journal.pone.0167878. eCollection 2016.

39.

Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada.

Knowles SR, Lee K, Paterson JM, Shah BR, Mamdani MM, Juurlink DN, Gomes T.

Can J Diabetes. 2017 Apr;41(2):138-142. doi: 10.1016/j.jcjd.2016.08.225. Epub 2016 Dec 15.

40.

Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies.

Gandhi S, McArthur E, Mamdani MM, Hackam DG, McLachlan RS, Weir MA, Burneo JG, Garg AX.

Epilepsia. 2016 Dec;57(12):2067-2079. doi: 10.1111/epi.13593. Epub 2016 Nov 29.

41.

The Cardiovascular Safety of Dutasteride.

Skeldon SC, Macdonald EM, Law MR, Huang A, Paterson JM, Mamdani MM, Juurlink D.

J Urol. 2017 May;197(5):1309-1314. doi: 10.1016/j.juro.2016.11.082. Epub 2016 Nov 16.

PMID:
27866006
42.

Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study.

Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Tu JV, Juurlink DN, Chu A, Mamdani MM.

JAMA Intern Med. 2017 Jan 1;177(1):61-66. doi: 10.1001/jamainternmed.2016.6851. Erratum in: JAMA Intern Med. 2017 Aug 1;177(8):1228.

PMID:
27820619
43.

Computerized Insulin Order Sets and Glycemic Control in Hospitalized Patients.

Wong B, Mamdani MM, Yu CH.

Am J Med. 2017 Mar;130(3):366.e1-366.e6. doi: 10.1016/j.amjmed.2016.09.034. Epub 2016 Nov 4.

PMID:
27818228
44.

Vasectomy and risk of prostate cancer: population based matched cohort study.

Nayan M, Hamilton RJ, Macdonald EM, Li Q, Mamdani MM, Earle CC, Kulkarni GS, Jarvi KA, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network (CDSERN).

BMJ. 2016 Nov 3;355:i5546. doi: 10.1136/bmj.i5546.

45.

Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults.

Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG, Li L, McArthur E, Weir MA, Garg AX.

Am J Kidney Dis. 2017 Jan;69(1):87-96. doi: 10.1053/j.ajkd.2016.08.020. Epub 2016 Oct 20.

PMID:
27773479
46.

Varenicline and Risk of Self-Harm: A Nested Case-Control Study.

Tadrous M, Martins D, Yao Z, Mamdani MM, Juurlink DN, Gomes T, Antoniou T.

PLoS One. 2016 Sep 23;11(9):e0163681. doi: 10.1371/journal.pone.0163681. eCollection 2016.

47.

The appropriateness and persistence of testosterone replacement therapy in Ontario.

Martins D, Yao Z, Tadrous M, Shah BR, Juurlink DN, Mamdani MM, Gomes T; Ontario Drug Policy Research Network.

Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):119-126. doi: 10.1002/pds.4083. Epub 2016 Aug 16.

PMID:
27528454
48.

The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario.

Vaid HM, Camacho X, Granton JT, Mamdani MM, Yao Z, Singh S, Juurlink DN, Gomes T.

Can Respir J. 2016;2016:6279250. doi: 10.1155/2016/6279250. Epub 2016 Apr 11.

49.

Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study.

Foster PD, Camacho X, Vigod S, Yao Z, Juurlink DN, Paterson JM, Mamdani MM, Martins D, Gomes T.

CMAJ Open. 2016 Jun 10;4(2):E292-7. doi: 10.9778/cmajo.20150095. eCollection 2016 Apr-Jun.

50.

Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.

Arora N, Knowles S, Gomes T, Mamdani MM, Juurlink DN, Carlisle C, Tadrous M.

Can J Psychiatry. 2016 Dec;61(12):758-765. doi: 10.1177/0706743716649190. Epub 2016 Jul 10.

Supplemental Content

Loading ...
Support Center